Thursday, September 18, 2025

Latest

The Solution To Antibiotic Resistance – With Cytophage CEO Dr Steven Theriault

FULL DISCLOSURE: This is sponsored content for Cytophage Technologies.

In this interview, Dr. Steven Theriault BSc, MSc, PhD, CEO of Cytophage Technologies Ltd (TSXV: CYTO), sits down with Small Cap Steve to shed light on Cytophage’s groundbreaking work in health science, specifically addressing bacterial infections through tailored bacteriophages. Bacteriophages, viruses that selectively infect and eliminate bacteria, offer an eco-friendly alternative to antibiotics.

Dr. Theriault emphasizes the pressing issue of antibiotic resistance and the critical need for innovative solutions. Cytophage’s technology, spanning human health, animal well-being, and food safety, presents a comprehensive approach. The interview explores the company’s mission to commercialize products globally, potentially revolutionizing bacterial infection treatments on a worldwide scale.


FULL DISCLOSURE: Cytophage Technologies is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cytophage Technologies. The author has been compensated to cover Cytophage Technologies on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why $10K Gold No Longer Sounds Crazy | Dan Wilton – First Mining Gold

The Pure Silver Set Up! | Joaquin Marias – Argenta Silver Corp

Why $30,000 Gold Isn’t Crazy! | Simon Marcotte – Northern Superior

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Cytophage Enters Letter Of Intent With Major Singapore-Based Agrifood Company

Cytophage Technologies (TSXV: CYTO) is focusing its efforts on expanding the commercialization of its phage...
Friday, June 21, 2024, 08:45:08 AM

Cytophage Develops Freeze-Dried Phage Tablets For Poultry

Cytophage Technologies (TSXV: CYTO) has announced the launch of a new product that it believes...
Thursday, August 15, 2024, 02:56:00 PM

Cytophage Enters Partnership To Launch Phage Clinical Treatment Program In Manitoba

Cytophage Technologies (TSXV: CYTO) announced a landmark agreement this morning that will see the establishment...
Thursday, December 12, 2024, 05:14:00 PM

McDonald’s E.coli Crisis: This Canadian Biotech May Have The Solution | Cytophage with Steven Theriault

In this interview, Dr. Steven Theriault, CEO & Chief Science Officer of Cytophage Technologies (TSXV:...
Saturday, November 16, 2024, 09:13:00 AM

Cytophage Adds 30-Year Biotech Exec To Its Board

Cytophage Technologies (TSXV: CYTO) has added bench strength to its board of directors this morning,...
Monday, May 27, 2024, 09:09:36 AM